Eli Lilly (LLY) Retatrutide Shows 28.3% Average Weight Loss in Phase 3 Trial Coinotag 00:26 Thu, 20 Aug
Will Strong Q2 Results and Higher 2026 Outlook Change Eli Lilly's (LLY) Narrative? Simply Wall St 08:42 Fri, 07 Aug
LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs Barchart 21:00 Wed, 05 Aug
Eli Lilly (NYSE:LLY) Beats Expectations in Strong Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations Barchart 12:21 Wed, 05 Aug
Eli Lilly (LLY) Wins FDA Breakthrough Status For Olomorasib In Pancreatic Cancer Simply Wall St 16:21 Tue, 04 Aug
Lilly (LLY) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures Zacks 15:15 Fri, 31 Jul
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know Zacks 15:05 Fri, 31 Jul
Weekly Buzz: AZN, GSK JNJ Approvals; Cuv Layoff, Regn, halo, Samsun Deals, Lly, Cldx Data RTT News 16:24 Fri, 24 Jul
